Cartesian Therapeutics, Inc. — Director's Dealing 2016

Dec 22, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SELECTA BIOSCIENCES INC (SELB)
CIK: 0001453687
Period of Report: 2016-12-19

Reporting Person: Keller Peter (Chief Business Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-12-19	Common Stock	S	4723	$18.58	Disposed	405	Direct

Footnotes

F1: These shares are restricted common stock which are subject to a right of repurchase by the Issuer until December 31, 2016.